Researchers used pharmacovigilance data to examine the onset of gastrointestinal adverse events associated with the use of biologic therapies for psoriasis.

Switching among biologic therapies is common practice in patients with rheumatoid arthritis who have an inadequate response or intolerable adverse events. Evidence from observational studies and ...

Investigators aimed to highlight aspects that may predict the time to relapse among patients with psoriasis who discontinued use of biologic therapy.

Biologic therapies now approved for use in inflammatory joint diseases are TNF inhibitors, T-cell modulators and B-cell depleters. They have all been shown to have clinical efficacy and are able ...

Infliximab and guselkumab were among the biologic therapies with the greatest treatment persistence in patients with psoriasis, whereas sex and specific psoriasis diagnostic codes had the most ...

Learn characteristics for nebulization: particle size, stability, viscosity, device interactions, efficacy. Explore key properties for optimizing biologic dry powder formulations: stabilize molecule, ...